InvestSMART

Finexia Financial Group Limited (ASX:FNX)

ALERT: Price-sensitive ASX Announcement for FNX
Current share price for FNX : $0.180 0.035 (24.14%)+
Announcement
Release
24 Oct 2025 1:21PM
Price at Release
$0.145
Full Release
download
Summary
Finexia Financial Group Limited announced an adjustment to its preliminary financial statements for the fiscal year ending 30 June 2025. After a further review, an additional impairment adjustment of $2.2 million was recognized concerning the company's investment in The Stay Company Income Fund, bringing the total impairment for the year to $6,213,463. This adjustment increased the group's reported loss before tax for FY25 to $6,820,416, compared to the previously reported $4,620,416. Additionally, a write-down of a receivable related to Dragonfly Biosciences was made for $543,039, as it was deemed unlikely to be recovered. The full-year audited financial statements were expected to be released on the same day as this announcement.
Key Points
  • Additional impairment of $2.2 million recognized for 'The Stay Company Income Fund'.
  • Total impairment for FY25 is $6,213,463.
  • Reported loss before tax increased to $6,820,416 from the preliminary $4,620,416.
  • Write-down of Dragonfly Biosciences receivable by $543,039.
  • Audited full-year financial statements expected to be released on 24 October 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.